TURNOVER (x1000 DKK)
NET PROFIT (x1000 DKK)
EMPLOYEES
Alligator Bioscience AB
Closing information (x1000 DKK)
Closing information | 2023/12 (consolidated) | 2022/12 (consolidated) | 2021/12 (consolidated) |
Turnover |
39,029
|
23,853
|
9,411 |
Financial expenses |
999
|
432
|
169 |
Earnings before taxes |
-166,969
|
-129,238
|
-103,061 |
EBITDA |
-160,190
|
-120,965
|
-94,833 |
Total assets |
79,560
|
113,322
|
242,280 |
Current assets |
52,517
|
82,068
|
217,858 |
Current liabilities |
66,549
|
43,120
|
34,478 |
Equity capital |
7,963
|
59,508
|
205,250 |
- share capital |
28,325
|
59,215
|
64,158 |
Employees (average) |
56
|
50
|
45 |
Financial ratios
Fiscal year | 2023/12 (consolidated) | 2022/12 (consolidated) | 2021/12 (consolidated) |
Solvency |
10.0%
|
52.5%
|
84.7% |
Turnover per employee |
697
|
477
|
209 |
Profit as a percentage of turnover |
-427.8%
|
-541.8%
|
-1095.1% |
Return on assets (ROA) |
-208.6%
|
-113.7%
|
-42.5% |
Current ratio |
78.9%
|
190.3%
|
631.9% |
Return on equity (ROE) |
-2096.8%
|
-217.2%
|
-50.2% |
Change turnover |
15,053
|
15,204
|
6,247 |
Change turnover % |
63%
|
176%
|
197% |
Chg. No. of employees |
6
|
5
|
-5 |
Chg. No. of employees % |
12%
|
11%
|
-10% |
Total value of public sale
Fiscal year | 2023/12 (consolidated) | 2022/12 (consolidated) | 2021/12 (consolidated) |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.